NervGen Pharma to Present at 2022 Virtual Growth Conference Presented by Maxim Group / Engages Apaton Finance to Provide Investor Relations Services in Europe
VANCOUVER, B.C. – NervGen Pharma Corp. (TSX-V: NGEN; OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, will… Read More




